Growth hormone treatment in non-growth hormone-deficient short children

Journal of Endocrinological Investigation

Volumn 28, Issue 4, 2005, Pages 193-198

  Loche, S ^a   Casini, M R ^a   Ubertini, G M ^b   Cappa, M ^b  

^a Osp Regionale per le Microcitemie   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Children; Growth hormone; Puberty; Short stature

Indexed keywords

GROWTH HORMONE; PLACEBO;

BODY HEIGHT; BONE MATURATION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; GROWTH CURVE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; IDIOPATHIC DISEASE; SHORT STATURE; SHORT SURVEY; TREATMENT OUTCOME; ADOLESCENT; CHILD; DELAYED PUBERTY; DRUG EFFECT; GENETICS; PATHOLOGY; REVIEW;

ADOLESCENT; BODY HEIGHT; CHILD; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; PUBERTY, DELAYED;

EID: 20444457579     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345367     Document Type: Short Survey

References (54)

1. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995, 127: 857-67.
2. Rochiccioli PO, Enjaume C, Tauber MT, Pienkowski C. Statistical study of 5473 results of nine pharmacological stimulation tests: a proposed weighting index. Acta Paediatr 1993, 82: 245-8.
3. Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996, 81: 3323-7
4. Tassoni P, Cacciari M, Cau M, et al. Variability of growth hormone response to pharmacological and sleep tests performed twice in short children. J Clin Endocrinol Metab 1990, 71: 230-4.
5. Tauber M, Moulin P, Pienkowski C, Journet B, Rochiccioli P. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completation of treatment. J Clin Endocrinol Metab 1997, 82: 352-6.
6. Maghnie M, Strigazzi C, Tinelli C, et al. Growth hormone deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999, 84: 1324-8.
7. Loche S, Bizzarri C, Maghnie M, et al. Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. J Pediatr 2002, 140: 445-9.
8. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984, 251: 2223-30.
9. Zadik Z, Chalew SA, Raiti S, Kowarski AA. Do short children secrete insufficient growth hormone? Pediatrics 1985, 76: 355-60.
10. Rose SR, Ross JL, Uriarte M, et al. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 1988, 319: 201-7.
11. Donaldson DL, Hollowell JG, Pan F, Gifford RA, Moore WV. Growth hormone secretory profiles: variation on consecutive nights. J Pediatr 1989, 115: 51-6.
12. Cacciari E, Tassoni P, Parisi G, et al. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1992, 74: 1284-9.
13. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995, 80: 15-1540.
14. Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. J Clin Endocrinol Metab 1996, 81: 2487-96.
15. Loche S, Colao A, Cappa M, et al. The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Metab 1997, 82: 861-4.
16. Marìn G, Domené HM, Barnes KM, Blackwell BJ, Cassorla F, Cutler GB. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994, 79: 537-41.
17. Martìnez AS, Domené HM, Ropelato GM, et al. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab 2000, 85: 4168-72.
18. Rudman D, Kutner MH, Blackston D, Cushman RA, Brain RP, Patterson JH. Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med 1981, 305: 123-31.
19. Van Vliet G, Styne DM, Kaplan SL, Grumbach MM. Growth hormone treatment for short stature. N Engl J Med 1983, 309: 1016-22.
20. Allen DB, Brook CGD, Bridges NA, Hindmarsh PC, Guyda HJ, Frazier D. Therapeuthic controversies: growth hormone (GH) treatment of non-GH deficient subjects. J Clin Endocrinol Metab 1994, 79: 1239-48.
21. Hindmarsh PC, Brook CGD. Effect of growth hormone on short normal children. BMJ 1987, 295: 573-7.
22. Hopwood NJ, Hinz RL, Gertner JM, et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993, 123: 215-22.
23. Moore WV, Moore KC, Gifford R, Hollowell JG, Donaldson DL. Long-term treatment of children with short stature and normal growth hormone secretion. J Pediatr 1992, 120: 702-8.
24. Loche S, Cambiaso P, Setzu S, et al. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr 1994, 125: 196-200.
25. Kaplowitz PB. Effect of growth hormone therapy on final versus predicted height in short twelve to sixteen-year-old boys without growth hormone deficiency. J Pediatr 1995, 126: 478-80.
26. Wit JM, Boersma B, de Muinck Keizer-Schrama SMPF, et al. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol (Oxf) 1995, 42: 365-72.
27. Hindmarsh PC, Brook CGD. Final height of short normal children treated with growth hormone. The Lancet 1996, 348: 13-6.
28. Wit JM, Rekers-Mombarg LTM on behalf of the Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 2002, 87: 604-11.
29. Kawai M, Momoi T, Yorifuji T, Yamanaka C, Sasaki H, Furusho K. Unfavorable effects of growth hormone therapy on the final height of boys with short sature not caused by growth hormone deficiency. J Pediatr 1997, 130: 205-9.
30. McCaughey ES, Mulligan J, Voss LD, Betts PR. Randomised trial of growth hormone in short normal girls. Lancet 1998, 351: 940-4.
31. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH. Comparison of final height of growth hormone-treated vs untreated children with idiopathic growth failure. J Clin Endocrinol Metab 1998, 83: 1075-9.
32. Hinz RL, Attie KM, Baptista J, Roche A for the Genentech Collaborative Group. Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 1999, 340: 502-7.
33. Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2004, 89: 3140-8.
34. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature. A meta-analysis. Arch Pediatr Adolesc Med 2002, 156: 230-40.
35. Bourguignon JP, Vanderweghe M, Vanderschueren-Lodeweyckx M, et al. Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. J Clin Endocrinol Metab 1986, 63: 376-82.
36. Balducci R, Toscano V, Mangiantini A, et al. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab 1995, 80: 3596-600.
37. Lanes R, Gunczler P. Final height after combined growth hormone and gonadotropin-releasing hormon analogue therapy in short healthy children entering into normally timed puberty. Clin Endocrinol (Oxf) 1998, 49: 197-202.
38. Pasquino AM, Pucarelli I, Roggini M, Segni M. Adult height in short normal girls treated with GnRH analogs and GH. J Clin Endocrinol Metab 2000, 85: 619-22.
39. Yanovski JA, Rose SR, Municchi G, et al. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 2003, 348: 908-17.
40. Volta C, Ghizzoni L, Buono T, Ferrari F, Virdis R, Bernasconi S. Final height in a group of untreated children with constitutional growth delay. Helv Paediatr Acta 1988, 43: 171-6.
41. Kalckreuth GV, Haverkamp F, Kessler M, Rosskamp RH. Constitutional delay of growth and puberty: do they really reach their target height? Horm Res 1991, 35: 222-5.
42. Crowne EC, Shalet SM, Wallace, Eminson DM, Price DA. Final height in boys with untreated constitutional delay in growth and puberty. Arch Dis Child 1990, 65: 1109-12.
43. LaFranchi S, Hanna CE, Mandel SH. Constitutional delay of growth: expected versus final adult height. Pediatrics 1991, 87: 82-7.
44. Loche S, Casini MR, Faedda A. The GH/IGF-I axis in puberty. Brit J Clin Prac 1996, 85 (Suppl): 1-4.
45. Bierich J. Treatment by hGH of constitutional delay of growth and adolescence. Acta Pediatr Scand Suppl 1986, 325: 71-5.
46. Loche S, Pintor C, Cambiaso P, et al. The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay. J Endocrinol Invest 1991, 14: 747-9.
47. Richman RA, Kirsch LR. Testosterone treatment in adolescent boys with constitutional delay in growth and development. N Engl J Med 1988, 319: 1563-7.
48. Joss EE, Schmidt HA, Zuppinger KA. Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height. J Clin Endocrinol Metab 1989, 69: 1109-15.
49. Bierich JR, Nolte K, Drews K, Brugman G. Constitutional delay of growth and adolescence. Results of short-term and long-term treatment with GH. Acta Endocrinol 1992, 127: 392-6.
50. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL, Bougneres PF. Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr 1991, 119: 29-34.
51. Blethen S, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996, 81: 1704-10.
52. Sandberg DE, Brook AE, Campos SP. Short stature: a psychosocial burden requiring growth hormone therapy? Pediatrics 1994, 94: 832-40.
53. Voss LD. Growth hormone therapy for the short normal child: who needs it and who wants it? J Pediatr 2000, 136: 103-10.
54. Downie AB, Mulligan J, McCaughey E, Stratford RJ, Betts PR, Voss LD. Psychological response to growth hormone treatment in short normal children. Arch Dis Child 1996, 75: 32-5.